Skip to content

Advanced BioMedical Technologies, Inc.

CIK 0001385799

← back to feed
Revenue (TTM)
$48.47K
+960.2% YoY Q3 Sep 2021
Net Income (TTM)
−$765.07K
+29.2% YoY Q3 Sep 2021
EPS Diluted (TTM)
—
Q3 Sep 2021
Gross Margin
77.2%
Q3 Sep 2021
Operating Margin
-887.2%
Q3 Sep 2021
Net Margin
-1,578.5%
Q3 Sep 2021
Free Cash Flow (TTM)
−$1.03M
Q3 Sep 2021
Cash
$6.98K
Q3 Sep 2021
Total Debt
—
Q3 Sep 2021
Shares Outstanding
70.22M sh
Q3 Sep 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings